Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001628280-26-029435

Chief Scientific Officer sold 4,170 shares at an average $13.12 ($54,694)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lorrain Daniel S. Chief Scientific Officer 2026-05-01 Sale 10b5-1 −3,870 $13.06 $50,542 143,842 D
Lorrain Daniel S. Chief Scientific Officer 2026-05-01 Sale 10b5-1 −300 $13.84 $4,152 143,542 D
Open-market sales · 4,170 sh · avg $13.12 · $54,694
Loading xslF345X06/wk-form4_1777671753.xml…